SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXCAN Pharma(AXCA)..A GUT FEELING!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (11)8/16/2000 11:47:31 PM
From: Sleepman  Read Replies (1) of 46
 
When I look at this company, I see a major opportunity in the H. pylori treatment. I really do not know where the PDT will take them. Expanded indications with ursodiol will still be shared with the more prominent product from Novartis. The H.pylori treatment would most likely be a big hit, that is, if the pill(or capsule), is not too big. Combining all that stuff will be a challenge. That said, if they can get it in and in a tolerable way, it will most likely be effective, as it is the most well studied way to treat the disease.
Still looking, and thinking about biting.
Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News